- Home
- PMT vs ELVN Comparison
PMT vs ELVN Comparison
Compare PMT & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMT | ELVN |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PMT | ELVN |
|---|---|---|
| Price | $12.50 | $17.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $14.13 | ★ $41.20 |
| AVG Volume (30 Days) | ★ 796.2K | 661.3K |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | ★ 12.84% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $564,655,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.66 | N/A |
| P/E Ratio | $13.59 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.60 | $13.30 |
| 52 Week High | $14.93 | $25.37 |
Technical Indicators
Market Signals| Indicator | PMT | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 33.61 |
| Support Level | $12.51 | $17.31 |
| Resistance Level | $12.71 | $20.47 |
| Average True Range (ATR) | 0.20 | 1.39 |
| MACD | -0.04 | -0.41 |
| Stochastic Oscillator | 3.48 | 6.66 |
Price Performance
Historical ComparisonAbout PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.